D’Silva A, Fox D, Nasser Y et al. Prevalence and risk factors for fatigue in adults with inflammatory bowel disease: a systematic review with Meta-analysis. Clin Gastroenterol Hepatol. 2021.
Borren NZ, van der Woude CJ, Ananthakrishnan AN. Fatigue in IBD: epidemiology, pathophysiology and management. Nat Rev Gastroenterol Hepatol. 2019;16(4):247–59.
Google Scholar
van Langenberg DR, Gibson PR. Systematic review: fatigue in inflammatory bowel disease. Aliment Pharmacol Ther. 2010;32(2):131–43.
Google Scholar
Chavarría C, Casanova MJ, Chaparro M, et al. Prevalence and factors Associated with fatigue in patients with inflammatory bowel disease: a Multicentre Study. J Crohn’s Colitis. 2019;13(8):996–1002.
Google Scholar
Frigstad S, Høivik M, Jahnsen J, et al. Fatigue is not associated with vitamin D deficiency in inflammatory bowel disease patients. World J Gastroenterol. 2018;24(29):3293–301.
Google Scholar
Hashash J, Ramos-Rivers C, Youk A, et al. Quality of Sleep and Coexistent Psychopathology have significant impact on fatigue burden in patients with inflammatory bowel disease. J Clin Gastroenterol. 2018;52(5):423–30.
Google Scholar
Huppertz-Hauss G, Høivik ML, Jelsness-Jørgensen LP, et al. Fatigue in a population-based cohort of patients with inflammatory bowel disease 20 years after diagnosis: the IBSEN study. Scand J Gastroenterol. 2017;52(3):351–8.
Google Scholar
Villoria A, García V, Dosal A, et al. Fatigue in out-patients with inflammatory bowel disease: prevalence and predictive factors. PLoS ONE. 2017;12(7):e0181435.
Google Scholar
Arnett SV, Clark IA. Inflammatory fatigue and sickness behaviour – lessons for the diagnosis and management of chronic fatigue syndrome. J Affect Disord. 2012;141(2–3):130–42.
Google Scholar
He X, Ng M, Choi K, et al. Synergistic interactions among fatigue, Sleep Disturbance, and Depression in Women with breast Cancer: a cross-sectional study. Oncol Nurs Forum. 2022;49(3):243–54.
Google Scholar
Fiorentino L, Rissling M, Liu L, Ancoli-Israel S. The Symptom cluster of sleep, fatigue and depressive symptoms in breast Cancer patients: severity of the Problem and Treatment options. Drug Discov Today Dis Models. 2011;8(4):167–73.
Google Scholar
Nocerino A, Nguyen A, Agrawal M, Mone A, Lakhani K, Swaminath A. Fatigue in Inflammatory Bowel diseases: etiologies and management. Adv Ther. 2020;37(1):97–112.
Google Scholar
Klusmann B, Fleer J, Tovote KA, et al. Trajectories of fatigue in inflammatory bowel disease. Inflamm Bowel Dis. 2021;27(12):1919–30.
Google Scholar
Conley S, Proctor DD, Jeon S, Sandler RS, Redeker NS. Symptom clusters in adults with inflammatory bowel disease. Res Nurs Health. 2017;40(5):424–34.
Google Scholar
Black CJ, Yiannakou Y, Guthrie EA, West R, Houghton LA, Ford AC. A Novel Method to Classify and Subgroup patients with IBS based on gastrointestinal symptoms and psychological profiles. Am J Gastroenterol. 2021;116(2):372–81.
Google Scholar
Polster AV, Palsson OS, Törnblom H, et al. Subgroups of IBS patients are characterized by specific, reproducible profiles of GI and non-GI symptoms and report differences in healthcare utilization: a population-based study. Neurogastroenterol Motil. 2019;31(1):e13483.
Google Scholar
Riggott C, Fairbrass KM, Black CJ, Gracie DJ, Ford AC. Novel symptom clusters predict disease impact and healthcare utilisation in inflammatory bowel disease: prospective longitudinal follow-up study. Alimentary pharmacology & therapeutics.; 2023.
Tinsley A, Macklin EA, Korzenik JR, Sands BE. Validation of the functional assessment of chronic illness therapy-fatigue (FACIT-F) in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2011;34(11–12):1328–36.
Google Scholar
Saraiva S, Cortez-Pinto J, Barosa R, et al. Evaluation of fatigue in inflammatory bowel disease – a useful tool in daily practice. Scand J Gastroenterol. 2019;54(4):465–70.
Google Scholar
Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Pyschiatry Res. 1989;28(2):193–213.
Google Scholar
Harvey RF, Bradshaw JM. A simple index of Crohn’s-disease activity. Lancet. 1980;8(1):514.
Google Scholar
Bennebroek Evertsz F, Hoeks CC, Nieuwkerk PT, et al. Development of the patient Harvey Bradshaw index and a comparison with a clinician-based Harvey Bradshaw index assessment of Crohn’s disease activity. J Clin Gastroenterol. 2013;47(10):850–6.
Google Scholar
Walmsley RS, Ayres RC, Pounder RE, Allan RN. A simple clinical colitis activity index. Gut. 1998;43(1):29–32.
Google Scholar
Bennebroek Evertsz’ F, Nieuwkerk PT, Stokkers PCF, et al. The patient simple clinical colitis activity index (P-SCCAI) can detect ulcerative colitis (UC) disease activity in remission: a comparison of the P-SCCAI with clinician-based SCCAI and biological markers. J Crohn’s Colitis. 2013;7(11):890–900.
Google Scholar
Marín-Jiménez I, Nos P, Domènech E, et al. Diagnostic performance of the simple clinical colitis activity index self-administered online at home by patients with Ulcerative Colitis: CRONICA-UC Study. Official J Am Coll Gastroenterol | ACG. 2016;111(2):261–8.
Google Scholar
Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–7.
Google Scholar
Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13.
Google Scholar
Lanza S, Dziak J, Huang L, Wagner A, Collins L. LCA Stata plugin users’ guide. methodology.psu.edu. Published 2018. Accessed 2023.
Weller B, Bowen N, Faubert S. Latent class analysis: a guide to best practice. J Black Psychol 2020;46.
Felger JC, Lotrich FE. Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications. Neuroscience. 2013;246:199–229.
Google Scholar
Frank P, Jokela M, Batty GD, Cadar D, Steptoe A, Kivimäki M. Association between Systemic Inflammation and individual symptoms of Depression: a pooled analysis of 15 Population-based Cohort studies. Am J Psychiatry. 2021;178(12):1107–18.
Google Scholar
Gaines LS, Slaughter JC, Schwartz DA, et al. Does reverse causality underlie the temporal relationship between Depression and Crohn’s Disease? Inflamm Bowel Dis. 2020;26(3):423–8.
Google Scholar
Bisgaard TH, Allin KH, Elmahdi R, Jess T. The bidirectional risk of inflammatory bowel disease and anxiety or depression: a systematic review and meta-analysis. Gen Hosp Psychiatry. 2023;83:109–16.
Google Scholar
Ozer M, Bengi G, Colak R, Cengiz O, Akpinar H. Prevalence of irritable bowel syndrome-like symptoms using Rome IV criteria in patients with inactive inflammatory bowel disease and relation with quality of life. Med (Baltim). 2020;99(19):e20067.
Google Scholar
Fuhrer R, Wessely S. The epidemiology of fatigue and depression: a French primary-care study. Psychol Med. 1995;25(5):895–905.
Google Scholar
Weinberger AH, Gbedemah M, Martinez AM, Nash D, Galea S, Goodwin RD. Trends in depression prevalence in the USA from 2005 to 2015: widening disparities in vulnerable groups. Psychol Med. 2018;48(8):1308–15.
Google Scholar
Pedersen CB, Mors O, Bertelsen A, et al. A comprehensive nationwide study of the incidence rate and lifetime risk for treated mental disorders. JAMA Psychiatry. 2014;71(5):573–81.
Google Scholar
Wittchen HU, Zhao S, Kessler RC, Eaton WW. DSM-III-R generalized anxiety disorder in the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51(5):355–64.
Google Scholar
Hanson KA, Loftus EV Jr., Harmsen WS, Diehl NN, Zinsmeister AR, Sandborn WJ. Clinical features and outcome of patients with inflammatory bowel disease who use narcotics: a case-control study. Inflamm Bowel Dis. 2009;15(5):772–7.
Google Scholar
Sanford D, Thornley P, Teriaky A, Chande N, Gregor J. Opioid use is associated with decreased quality of life in patients with Crohn’s disease. Saudi J Gastroenterol. 2014;20(3):182–7.
Google Scholar
Targownik LE, Nugent Z, Singh H, Bugden S, Bernstein CN. The prevalence and predictors of opioid use in inflammatory bowel disease: a population-based analysis. Am J Gastroenterol. 2014;109(10):1613–20.
Google Scholar
Busingye D, Pollack A, Chidwick K. Prevalence of inflammatory bowel disease in the Australian general practice population: a cross-sectional study. PLoS ONE. 2021;16(5):e0252458.
Google Scholar
Iskandar H, Linan E, Patel A, et al. Self-reported sleep disturbance in Crohn’s disease is not confirmed by objective sleep measures. Sci Rep. 2020;10(1):1980.
Google Scholar
Aluzaite K, Al-Mandhari R, Osborne H, et al. Detailed Multi-dimensional Assessment of fatigue in inflammatory bowel disease. Inflamm Intest Dis. 2019;3(4):192–201.
Google Scholar
Vogelaar L, van’t Spijker A, van Tilburg AJ, Kuipers EJ, Timman R, van der Woude CJ. Determinants of fatigue in Crohn’s disease patients. Eur J Gastroenterol Hepatol. 2013;25(2):246–51.
Google Scholar
Hashash JG, Ramos-Rivers C, Youk A, et al. Quality of Sleep and Coexistent Psychopathology have significant impact on fatigue burden in patients with inflammatory bowel disease. J Clin Gastroenterol. 2018;52(5):423–30.
Google Scholar
Sinha P, Calfee CS, Delucchi KL. Practitioner’s guide to latent class analysis: methodological considerations and common pitfalls. Crit Care Med. 2021;49(1):e63–79.
Google Scholar
link